2024年欧洲糖尿病研究协会年会会议纪要:糖尿病及代谢相关疾病管理的学术进展  

Proceedings of the 2024 annual meeting of European Association for the Study of Diabetes:Advances in management of diabetes and metabolic diseases

作　　者：龚颖芸 李悦 周红文[1] Gong Yingyun;Li Yue;Zhou Hongwen(Department of Endocrinology,the First Affiliatted Hospital of Nanjing Medical University,Nanjing 210029,China;Department of Endocrinology,the Affiliated Jiangsu Shengze Hospital of Nanjing Medical University,Suzhou 215200,China)

机构地区：[1]南京医科大学第一附属医院(江苏省人民医院)内分泌科,210029 [2]南京医科大学附属江苏盛泽医院内分泌科,苏州215200

出　　处：《中华内分泌代谢杂志》2025年第1期70-75,共6页Chinese Journal of Endocrinology and Metabolism

基　　金：国家自然科学基金(82170882);江苏省优秀青年基金(BK20230075)。

摘　　要：第60届欧洲糖尿病研究协会年会于2024年9月在西班牙马德里顺利召开并圆满落幕, 来自全球130多个国家的学者及行业领袖共同探讨了糖尿病及代谢相关疾病领域的最新研究成果、治疗方法和未来发展趋势。本文就本次大会报告的克劳德·伯纳德奖、糖尿病管理的新进展、肥胖对糖尿病的影响和新药研究、代谢功能障碍相关脂肪性肝病诊治新进展等方面内容进行概述。The 60th annual meeting of the European Association for the Study of Diabetes(EASD),held in Madrid,Spain,in September 2024,convened leading physicians and researchers from more than 130 countries.This premier event shared and discussed advances in diagnosis and treatment,as well as future trends in diabetes and metabolic disease research.Key topics included the presentation of the Claude Bernard Prize,advancements in diabetes management strategies,the interplay between obesity and diabetes,novel therapeutic developments,and emerging diagnostic and treatment approaches for metabolic dysfunction-associated steatotic liver disease.

关 键 词：糖尿病 肥胖 代谢功能障碍相关脂肪性肝病 欧洲糖尿病研究协会 

分 类 号：R587.1[医药卫生—内分泌]